Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000154895.18269.67
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;45:811.)
© 2005 American Heart Association, Inc.
Original Articles |
Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis Population
The 58th Annual Fall Conference and Scientific Sessions
From the Division of Nephrology and Hypertension (K.K.-Z., R.D.K., J.D.K.), Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, Calif; School of Public Health (R.D.K., S.G., J.D.K.), University of California, Los Angeles; DaVita, Inc. (C.J.M.), El Segundo, Calif; and Department of Statistics (S.G.), University of California, Los Angeles.
Correspondence to Kamyar Kalantar-Zadeh, MD, PhD, MPH, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, 1000 W Carson St, Torrance, CA 90509-2910. E-mail kamkal{at}ucla.edu
Maintenance hemodialysis patients in the United States have a high prevalence (
80%) of systolic hypertension and a high mortality (20% per year). Some reports indicate a paradoxical association between hypertension and morality in hemodialysis patients (ie, a normal to low blood pressure is associated with poor outcome), whereas high pressure confers survival advantages, a phenomenon referred to as "reverse epidemiology." We hypothesized that malnutrition-inflammation complex syndrome may be a cause of this paradoxical association. We studied a 15-month cohort of 40 933 hemodialysis patients in the United States whose predialysis and postdialysis blood pressure values were recorded routinely during each hemodialysis treatment. Patients were 59.8±15.3 years old; 54% were women and 46% diabetics. Cox proportional hazard models were used for blood pressure categories (systolic <110, 
190 mm Hg; diastolic <50, 110; and increments of 10 mm Hg in between). Unadjusted, case-mix and dialysis dose–adjusted, and additional malnutrition-inflammation–adjusted hazard ratios of all-cause and cardiovascular death showed progressively increasing all-cause and cardiovascular death risk for decreasing blood pressure values. The lowest mortality was associated with predialysis systolic pressure of 160 to 189 mm Hg, whereas normal to low predialysis pressure values were associated with significantly increased mortality. Adjustment for the malnutrition-inflammation mitigated only a small portion of paradoxical associations between the low blood pressure and mortality. Predialysis systolic hypertension remained a significant predictor of highest all-cause and cardiovascular survival rate. Although these associations may not be causal, they call into question whether treatment goals for the general population can be applied to dialysis patients or other similar populations.
Key Words: epidemiology • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  R. Agarwal, T. Metiku, G. G. Tegegne, R. P. Light, Z. Bunaye, D. M. Bekele, and K. Kelley Diagnosing Hypertension by Intradialytic Blood Pressure Recordings Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1364 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rohrscheib, O. B. Myers, K. S. Servilla, C. D. Adams, D. Miskulin, E. J. Bedrick, W. C. Hunt, D. E. Lindsey, D. Gabaldon, P. G. Zager, et al. Age-related Blood Pressure Patterns and Blood Pressure Variability among Hemodialysis Patients Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1407 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Trivedi, Q. Xiang, and J. P. Klein Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients Nephrol. Dial. Transplant., August 5, 2008; (2008) gfn426v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tepel, W. Hopfenmueller, A. Scholze, A. Maier, and W. Zidek Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients Nephrol. Dial. Transplant., May 29, 2008; (2008) gfn304v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Kovesdy, D. L. Regidor, R. Mehrotra, J. Jing, C. J. McAllister, S. Greenland, J. D. Kopple, and K. Kalantar-Zadeh Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 999 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Johansen Exercise in the End-Stage Renal Disease Population J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1845 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kalantar-Zadeh, J. D. Kopple, D. L. Regidor, J. Jing, C. S. Shinaberger, J. Aronovitz, C. J. McAllister, D. Whellan, and K. Sharma A1C and Survival in Maintenance Hemodialysis Patients Diabetes Care, May 1, 2007; 30(5): 1049 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Kilpatrick, C. J. McAllister, C. P. Kovesdy, S. F. Derose, J. D. Kopple, and K. Kalantar-Zadeh Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race J. Am. Soc. Nephrol., January 1, 2007; 18(1): 293 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C.Y. Tong, A. P.S. Kong, W.-Y. So, M. H.L. Ng, X. Yang, M. C.Y. Ng, R. C.W. Ma, C.-S. Ho, C. W.K. Lam, C.-C. Chow, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care, November 1, 2006; 29(11): 2439 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Habib, B. C. Baird, J. K. Leypoldt, A. K. Cheung, and A. S. Goldfarb-Rumyantzev The association of lipid levels with mortality in patients on chronic peritoneal dialysis Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2881 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.H. Messerli, G. Mancia, C.R. Conti, A.C. Hewkin, S. Kupfer, A. Champion, R. Kolloch, A. Benetos, C.J. Pepine, K. Nakagawa, et al. Lowering of Blood Pressure--The Lower, the Better?: Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884-893, 2006 J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2345 - 2352. [Full Text] [PDF]
|
|
|
|
|
|
C. P. Kovesdy, B. K. Trivedi, K. Kalantar-Zadeh, and J. E. Anderson Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1257 - 1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Regidor, J. D. Kopple, C. P. Kovesdy, R. D. Kilpatrick, C. J. McAllister, J. Aronovitz, S. Greenland, and K. Kalantar-Zadeh Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1181 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Y. Wu, C. S. Shinaberger, D. L. Regidor, C. J. McAllister, J. D. Kopple, and K. Kalantar-Zadeh Association between Serum Bicarbonate and Death in Hemodialysis Patients: Is It Better to Be Acidotic or Alkalotic? Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 70 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kalantar-Zadeh, D. L. Regidor, C. J. McAllister, B. Michael, and D. G. Warnock Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3070 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kalantar-Zadeh, R. D. Kilpatrick, N. Kuwae, C. J. McAllister, H. Alcorn Jr, J. D. Kopple, and S. Greenland Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1880 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kalantar-Zadeh, C. J. McAllister, and L. G. Miller Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1662 - 1669. [Abstract] [Full Text] [PDF]
|
|